|
Aug 30
|
JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab
|
|
Aug 30
|
Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data
|
|
Aug 29
|
Neurocrine Stock Down 19% on Mixed Schizophrenia Study Results
|
|
Aug 28
|
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs
|
|
Aug 28
|
One Fulcrum Therapeutics Insider Raised Their Stake In The Previous Year
|
|
Aug 28
|
Addex Stock Soars on Crucial Update From Indivior Research Deal
|
|
Aug 28
|
Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review
|
|
Aug 27
|
Fulcrum Therapeutics to Participate in Upcoming September Conferences
|
|
Aug 27
|
Insmed Stock Surges 168% in the Past Six Months: Here's Why
|
|
Aug 27
|
Rhythm Stock Up as FDA Accepts Obesity Drug sNDA for Younger Kids
|
|
Aug 27
|
The Zacks Analyst Blog Fulcrum Therapeutics, Heritage Insurance, Latham Group, Seanergy Maritime and BrainsWay
|
|
Aug 26
|
5 Best Small-Cap Stocks to Benefit From Interest Rate Cuts
|
|
Aug 26
|
AstraZeneca (AZN) Denies Rumors About UK Facility Relocation
|
|
Aug 26
|
Sutro Biopharma (STRO) Rises 9% in the Past Week: Here's Why
|
|
Jul 24
|
Fulcrum Therapeutics to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, July 31, 2024, at 8:00 a.m. ET
|
|
May 15
|
Wall Street Analysts See a 69.15% Upside in Fulcrum Therapeutics (FULC): Can the Stock Really Move This High?
|
|
May 14
|
Will Fulcrum Therapeutics (NASDAQ:FULC) Spend Its Cash Wisely?
|
|
May 14
|
Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 13
|
Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
|
|
May 13
|
Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income Projections Amid Strategic ...
|